[1] Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Gustafson S, Li Q, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L. Us renal data system 2010 annual data report. Am J Kidney Dis, 2011, 57(S1): A8, e1-526.
[2] Kanwar YS, Sun L, Xie P, Liu FY, Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol, 2011, 6(1): 395-423.
[3] Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia, 1996, 39(8): 940-945.
[4] Harjutsalo V, Katoh S, Sarti C, Tajima N, Tuomilehto J. Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes, 2004, 53(9): 2449-2454.
[5] Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) dia-betes mellitus. Diabetologia, 1990, 33(7): 438-443.
[6] Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, Freedman BI, Dekkers OM, Baelde HJ. Genetic associations in diabetic nephropathy: A meta-analysis. Diabe-tologia, 2011, 54(3): 544-553.
[7] Wang FR, Fang QQ, Yu NL, Zhao DY, Zhang YM, Wang J, Wang Q, Zhou XF, Cao XJ, Fan XY. Association between genetic polymorphism of the angiotensin-converting en-zyme and diabetic nephropathy: A meta-analysis comprising 26, 580 subjects. J Renin Angiotensin Aldosterone Syst, 2012, 13(1): 161-174.
[8] Wang Y, Ng MCY, So WY, Tong PCY, Ma RCW, Chow CC, Cockram CS, Chan JCN. Prognostic effect of inser-tion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in chinese patients with type 2 diabetes. Diabetes Care, 2005, 28(2): 348-354.
[9] So WY, Ma RC, Ozaki R, Tong PC, Ng MC, Ho CS, Lam CW, Chow CC, Chan WB, Kong AP, Chan JC. Angio-tensin-converting enzyme (ace) inhibition in type 2, dia-betic patients--interaction with ace insertion/deletion polymorphism. Kidney Int, 2006, 69(8): 1438-1443.
[10] 马青云. 糖尿病肾病遗传学研究现状. 中华糖尿病杂志, 2012, 4(1): 7-8.
[11] Freedman BI, Bowden DW, Rich SS, Xu J, Wagenknecht LE, Ziegler J, Hicks PJ, Langefeld CD. Genome-wide linkage scans for renal function and albuminuria in type 2 diabetes mellitus: The diabetes heart study. Diabet Med, 2008, 25(3): 268-276.
[12] Osterholm AM, He B, Pitkaniemi J, Albinsson L, Berg T, Sarti C, Tuomilehto J, Tryggvason K. Genome-wide scan for type 1 diabetic nephropathy in the finnish population reveals suggestive linkage to a single locus on chromo-some 3q. Kidney Int, 2007, 71(2): 140-145.
[13] Placha G, Poznik GD, Dunn J, Smiles A, Krolewski B, Glew T, Puppala S, Schneider J, Rogus JJ, Rich SS, Duggirala R, Warram JH, Krolewski AS. A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin c levels in extended families with type 2 diabetes. Diabetes, 2006, 55(12): 3358-3365.
[14] Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Elston RC, Freed-man BI, Goddard KA, Guo X, Hanson RL, Ipp E, Iyengar SK, Jun G, Kao WH, Kasinath BS, Kimmel PL, Klag MJ, Knowler WC, Nelson RG, Parekh RS, Quade SR, Rich SS, Saad MF, Scavini M, Smith MW, Taylor K, Winkler CA, Zager PG, Shah VO. Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: The family investigation of nephropathy and diabetes (find). Diabetes, 2008, 57(1): 235-243.
[15] Wessman M, Forsblom C, Kaunisto MA, Söderlund J, Ilonen J, Sallinen R, Hiekkalinna T, Parkkonen M, Max-well AP
